It’s been years since we first heard about the “gummy bear implant” being used in breast augmentation around the world. Finally, Allergan has received approval from the U.S. Food and Drug Administration (FDA) to market the new breast implant for cosmetic procedures.
The FDA’s approval of The Natrelle 410® Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implant (a.k.a. the gummy bear implant), is based on seven years of data from 941 different women. Dr. Rudderman was selected by Allergan to participate in this study due to his superior breast surgery skills for both breast reconstruction & breast augmentation. The Natrelle 410® Implant is now one of four FDA-approved silicone gel-filled breast implants available in the U.S.
“The FDA approval of Natrelle 410® shaped gel implants provides an important new alternative to traditional round implants for women considering breast augmentation, breast reconstruction or breast revision surgery,” says David E.I. Pyott, Allergan’s Chairman of the Board, President and Chief Executive Officer. “The Natrelle 410® is the most selected shaped gel implant in markets where the product is already available, such as Europe and Canada.”
So, how does this implant differ from others? Shaped to mimic the natural slope of the breast, the gel implant is filled with a cohesive silicone gel that is not only soft to the touch, but also allows the implant to hold its shape over time with no risk of deflating or leaking.
Given the option, choosing Allergan’s Natrelle 410® implant makes perfect sense to woman considering breast surgery. After all, a woman’s breasts are not perfectly shaped hemispheres, but are a gently sloped teardrop shape. Allergan’s Natrelle 410® breast implant achieves this naturally beautiful slope of a woman’s breast perfectly. If you’re considering breast surgery, ask Dr. Rudderman about the Natrelle 410® breast implant. You will be happy you did!